Biden proposes extending Medicare price negotiations to more drugs
The White House put out word this morning that as part of its campaign to keep the Medicare program for seniors solvent, its newly formed drug price negotiations should be extended to even more drugs and take effect more quickly.
Building on the Inflation Reduction Act, which gave Medicare the authority to negotiate prices for a select number of high-cost drugs (building up to 60 by 2029), President Joe Biden said in a statement that his budget
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,800+ biopharma pros reading Endpoints daily — and it's free.